Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
BMC Cancer
|
November 25, 2021
The effect of hypoxia on PD-L1 expression in bladder cancer
Vicky Smith, Debayan Mukherjee, Sapna Lunj, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group
Joachim Yahalom, Tim Illidge, Lena Specht, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 14, 2011
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial
Lisa Lowry, Paul Smith, Wendi Qian, et al.
British Journal of Haematology
|
May 20, 2016
Guidelines for the management of diffuse large B-cell lymphoma
Sridhar Chaganti, Tim Illidge, Sally Barrington, et al.
European Journal of Haematology
|
September 27, 2017
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
Paul J Bröckelmann, Erin A Zagadailov, Shelby L Corman, et al.
Leukemia & Lymphoma
|
April 27, 2013
Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant
Sally Arai, Michelle Fanale, Sven DeVos, et al.
Leukemia & Lymphoma
|
October 19, 2017
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany
Erin A Zagadailov, Shelby Corman, Viktor Chirikov, et al.
British Journal of Haematology
|
October 15, 2013
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma
Graham P Collins, Anne N Parker, Christopher Pocock, et al.
British Journal of Haematology
|
November 23, 2021
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline
Christopher P Fox, Matthew J Ahearne, Ruth Pettengell, et al.
British Journal of Haematology
|
January 4, 2012
Guidelines on the investigation and management of follicular lymphoma
Christopher McNamara, John Davies, Martin Dyer, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
BMC Cancer
|
November 25, 2021
The effect of hypoxia on PD-L1 expression in bladder cancer
Vicky Smith, Debayan Mukherjee, Sapna Lunj, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group
Joachim Yahalom, Tim Illidge, Lena Specht, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 14, 2011
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial
Lisa Lowry, Paul Smith, Wendi Qian, et al.
British Journal of Haematology
|
May 20, 2016
Guidelines for the management of diffuse large B-cell lymphoma
Sridhar Chaganti, Tim Illidge, Sally Barrington, et al.
European Journal of Haematology
|
September 27, 2017
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
Paul J Bröckelmann, Erin A Zagadailov, Shelby L Corman, et al.
Leukemia & Lymphoma
|
April 27, 2013
Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant
Sally Arai, Michelle Fanale, Sven DeVos, et al.
Leukemia & Lymphoma
|
October 19, 2017
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany
Erin A Zagadailov, Shelby Corman, Viktor Chirikov, et al.
British Journal of Haematology
|
October 15, 2013
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma
Graham P Collins, Anne N Parker, Christopher Pocock, et al.
British Journal of Haematology
|
November 23, 2021
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline
Christopher P Fox, Matthew J Ahearne, Ruth Pettengell, et al.
British Journal of Haematology
|
January 4, 2012
Guidelines on the investigation and management of follicular lymphoma
Christopher McNamara, John Davies, Martin Dyer, et al.
Page
of 7